Albemarle’s lithium rebound gains force as adjusted EBITDA reaches US$646 million

Albemarle Corporation (NYSE:ALB) has put lithium pricing back in the driver’s seat, reporting a 186% year-on-year jump in third-quarter adjusted EBITDA to US$645.5 million. Net sales rose 19% to US$1.553 billion, while GAAP net income attributable to Albemarle reached US$296.8 million, reversing a US$160.7 million loss a year earlier.

The quarter’s adjusted net income was US$353.6 million, or US$2.58 a diluted share, compared with US$19.5 million and a US$0.19 loss per share in the prior-year period. The adjusted figures exclude US$56.1 million of non-recurring and other unusual items, including restructuring charges, strategic cost-saving costs and other adjustments; the GAAP result remains the cleaner measure of what Albemarle actually reported.

Lithium pricing overwhelms lower Energy Storage volumes

Energy Storage generated US$1.119 billion of revenue, up 58%, and US$559.8 million of adjusted EBITDA, up 351%. Average realised pricing almost doubled to US$20.02 per kilogram of lithium carbonate equivalent from US$10.28, more than offsetting an 19% decline in sales volume to 56 kilotonnes of LCE.

Albemarle said the volume comparison was affected by unusual timing in the third quarter of 2025, when destocking and elevated spodumene shipments produced a record quarter. The latest result was also partly restrained by the processing of higher-priced spodumene inventory and increased Chilean commissions. Talison’s Chemical Grade Plant 3 reached 30 days of nameplate performance in September, although its broader ramp-up has been delayed by a June fire.

Specialties outlook rises as costs improve

Specialties supplied the less dramatic but arguably more durable part of the quarter. Revenue increased 13% to US$388.6 million, with pricing up 10% and volumes up 3%, while adjusted EBITDA rose 31% to US$98.7 million. Albemarle cited stronger bromine and derivatives pricing, higher volumes, productivity gains and record quarterly production at the Jordan Bromine Company joint venture.

The company lifted its full-year 2026 Specialties adjusted EBITDA outlook to US$350 million-US$375 million from US$275 million-US$325 million. That improvement is expected to absorb supply-chain cost escalation linked to the conflict in the Middle East, with demand described as steady in automotive and petrochemicals and modestly growing in semiconductors, oil and gas, flame retardants and pharmaceuticals.

Lower capital spending strengthens the balance sheet cushion

Albemarle reduced its 2026 capital expenditure forecast to US$300 million-US$350 million from approximately US$500 million, citing capital-efficiency gains and the resequencing of early-stage projects. It generated US$1.462 billion of operating cash flow and US$1.2 billion of free cash flow in the first nine months, while debt stood at US$1.9 billion and estimated liquidity at US$3.4 billion at September 30.

The immediate catch is that the lithium recovery remains highly price-sensitive. Albemarle expects fourth-quarter Energy Storage revenue and adjusted EBITDA to decline sequentially as market pricing falls and higher-cost spodumene inventory moves through the business. Its full-year scenarios range from US$0.9 billion-US$1.0 billion of adjusted EBITDA at an average lithium price of about US$10 per kilogram LCE to US$4.2 billion-US$4.4 billion at about US$30, a spread that says as much about commodity exposure as it does about operating leverage.